Differential expression of somatostatin receptor (SSTR) subtypes across a spectrum of neuroendocrine neoplasms (NENs).


Emil Lou, Nishant Gandhi, Alex Farrell, Joanne Xiu, Andreas Seeber, Muhammad Shaalan Beg, Minnu Monu, Sourat Darabi, Michael J. Demeure, Jim Abraham, Matthew James Oberley, John Marshall, Heloisa P. Soares

Key Finding:

Next-generation sequencing can define characteristic differences in the genomic landscape across SSTR subtypes in high-grade and low-grade neuroendocrine neoplasms. Incorporating the molecular profiling of neuroendocrine neoplasms can thus aid in advancing the development of more tailored therapeutic strategies. 

Download Publication